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OBJECTIVE
Offspring of pregnancies affected by gestational diabetes mellitus (GDM) are at in-
creased risk of the development of type 2 diabetes. However, the extent to which
these dysmetabolic traits may be due to offspring and/or maternal adiposity is un-
known. We examined body composition and associated cardiometabolic traits in
561 9- to 16-year-old offspring of mothers with GDM and 597 control offspring.
RESEARCH DESIGN AND METHODS
We measured anthropometric characteristics; puberty status; blood pressure; and
fasting glucose, insulin, C-peptide, and lipid levels; and conducted a DEXA scan in a
subset of the cohort. Differences in the outcomes between offspring ofmothers with
GDMand control subjectswere examined using linear and logistic regressionmodels.
RESULTS
After adjustment for age and sex, offspring of mothers with GDM displayed higher
weight, BMI, waist-to-hip ratio (WHR), systolic blood pressure, and resting heart rate
and lower height. Offspring ofmotherswith GDMhad higher total and abdominal fat
percentages and lower muscle mass percentages, but these differences disappeared
after correction for offspring BMI. The offspring of mothers with GDM displayed
higher fasting plasma glucose, insulin, C-peptide, HOMA-insulin resistance (IR), and
plasma triglyceride levels, whereas fasting plasma HDL cholesterol levels were de-
creased. Female offspring ofmotherswith GDMhad an earlier onset of puberty than
control offspring. Offspring ofmothers with GDMhad signiﬁcantly higher BMI,WHR,
fasting glucose, and HOMA-IR levels after adjustment for maternal prepregnancy
BMI, and glucose and HOMA-IR remained elevated in the offspring of mothers with
GDM after correction for both maternal and offspring BMIs.
CONCLUSIONS
In summary, adolescent offspring of womenwith GDM show increased adiposity, an
adverse cardiometabolic proﬁle, and earlier onset of puberty among girls. Increased
fasting glucose and HOMA-IR levels among the offspring of mothers with GDMmay
be explained by the programming effects of hyperglycemia in pregnancy.
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Offspring of mothers with gestational di-
abetes mellitus (GDM) are at increased
risk for the development of obesity, insu-
lin resistance (IR), and type 2 diabetes
(1–4). Maternal obesity is one of the
most important risk factors of both
GDM and offspring adiposity, and the ex-
tent to which maternal obesity explains
offspring adiposity and associated dysme-
tabolic traits independent of other factors
including hyperglycemia in pregnancy is
controversial and the particular impact of
hyperglycemia per se on offspring meta-
bolic health is debated (5,6). Whereas in-
tensiﬁed glucose-lowering treatment of
women with GDM reduced macrosomia
at birth, no beneﬁcial effect on offspring
adiposity or associated cardiometabolic
dysfunctions at ages 5–10 years was seen
(7,8).
Few studies have examined the impact
of GDM on adiposity and IR during ado-
lescence, and the joint inﬂuence of these
factors on the onset of puberty. Early on-
set is associated with emotional chal-
lenges and can result in short stature,
both of which may have inﬂuence at the
individual and public health levels. One
study (9) examined the impact of GDM
onadiposity andmetabolic variables across
ﬁve puberty stages and found no differ-
ence in puberty development between off-
spring of mothers with GDM and control
subjects but found an increase in body fat
percentages during all Tanner stages.
Previous studies of offspring of moth-
ers with GDM have been variable in size
(n = 24–1,475 cases)with the largest stud-
ieshavingonly a fewclinicalmeasurements
such as height, weight, and waist-to-hip
ratio (WHR) in the offspring (10,11). In
the current study, we report clinical and
metabolic characteristics including body
composition and puberty status in a large
cohort of 9- to 16-year-old offspring of
women with and without previous GDM
who were recruited from the Danish Na-
tional Birth Cohort (DNBC) (12). Addition-
ally, we examine the association of GDM
with offspring metabolic disease and pu-
berty development while accounting for
offspring andmaternal degree of adiposity.
RESEARCH DESIGN AND METHODS
Subjects
Participantswere recruited from theDNBC,
which enrolled 91,827 primarily Caucasian
women collectively contributing.100,000
pregnancies between January 1996 and
October 2002, as described in detail pre-
viously (12). Brieﬂy, data collection
included four telephone interviews in
gestation weeks 12 and 30, and 6 and
18 months postpartum. From the DNBC,
we included 1,350 women with a diagno-
sis of GDM and 2,629 randomly selected
control subjects and invited them and
their offspring to participate in a clini-
cal follow-up examination during the pe-
riod March 2012 to April 2014 (13). In
total, 608 (44%) case mother-offspring
pairs and 626 (28%) control mother-
offspring pairs participated. Themain rea-
son for nonparticipation was lack of time.
We excluded multiple births including 33
twins (31 from mothers with GDM) and
3 triplets (all from mothers with GDM),
and only included the ﬁrst sibling in our
analyses (80 siblings in total, 40 kept in
analyses) to avoid correlated measures.
This left us with 561 offspring of mothers
with GDM and 597 control offspring in
our analyses (Fig. 1). The offspring were
9–16years old at the timeof examination.
The study was approved by the Regional
Scientiﬁc Ethics Committee for themunic-
ipalities of Copenhagen and Frederiksberg
(H-4–2011–045 and H-4–2013–129). Con-
sent from both parents was essential for
the participation of the child in the study.
Diagnosis of GDM
Initially, we used two different sources to
identify women with a history of GDM.
Women were classiﬁed with a diagnosis
of GDM if they had responded positively
to a question about GDM in at least one
of the interviews conducted in gestation
week 30 or 6months postpartum, respec-
tively. Furthermore, we used the Danish
National Patient Register to extract infor-
mation about diagnoses of GDM (ICD-10
classiﬁcations O244 and O249). Women
with a self-reported diagnosis of GDM
and/or an ICD-10 diagnosiswere classiﬁed
as having had suspected GDM in our main
analyses. Additionally, in sensitivity analyses
we used an alternative diagnosis of GDM de-
ﬁned as “best clinical judgement.” This di-
agnosis was based on a thorough review
by two clinicians of the hospital records of
96.5% of all GDM case patients classiﬁed
as described above. The best clinical
judgement or veriﬁed GDM diagnosis
was based on available data such as blood
glucose measurements, if available, or on
other notes from the doctor indicating
GDM. In the sensitivity analyses in the
present article, only those with GDM
based upon the best clinical judgment
were included (n = 332).
InDenmark, a risk factor–based screen-
ing for GDM with a 75-g diagnostic oral
glucose tolerance test was recommended
during 1996–2002. If results from a 75-g
3-h oral glucose tolerance test were avail-
able from the hospital records, GDM was
diagnosed if two or more glucose values
exceeded the mean 6 3 SDs on a curve
based on a group of 40 healthy, nonobese,
nonpregnant Danishwomenwithout a fam-
ily history of diabetes. However, in a few
smaller departments the World Health Or-
ganization criteria were used. The diagnosis
of the GDMwomen is described in detail in
the study by Olsen et al. (14).
Clinical Examinations
All participating offspring underwent a
clinical examination that included anthro-
pometric, metabolic, and body compo-
sition measurements. Offspring were
weighed without shoes and were lightly
dressed. We measured waist circumfer-
ence at the level of the umbilicus using a
soft tape on standing subjects. Hip circum-
ference was measured over the widest
part of the gluteal region. After 10 min,
the resting blood pressure and heart rate
weremeasuredwithanOmronbloodpres-
sure devicewith the offspring in the supine
position. All measurements were taken
twice, and if the differences exceeded
0.5 cm or 0.5 kg for the anthropometric
measurements, or 5mmHg for blood pres-
sure measurements, a third measurement
was taken. In all analyses, the mean value
of the measurements was used.
Offspring metabolic outcomes were
obtained from a fasting blood sample
that was taken during the clinical exami-
nation, and plasma, serum, buffy coat, and
whole blood (PAXgene) were collected.
Blood samples for glucose measurements
were drawn in K-oxalate-Na-ﬂuoride vials
and in lithium-heparin vials for insulin,
C-peptide, and lipid traits. All parameters
were measured using standard labora-
tory methods on the Modular P-module
(Roche, Mannheim, Germany). Coefﬁcients
of variancewere 4–5% for glucose, insulin,
total cholesterol, LDL cholesterol, HDL cho-
lesterol, and triglycerides and 8% for
C-peptide. HOMA-IR was calculated as fol-
lows: ([(fasting plasma insulin (pmol/L) 3
fasting plasma glucose (mmol/L)/22.5]3
0.144) (15).
In order to determine the puberty
status of the study participants, clinical
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evaluations were made including puber-
tal staging of breast development and
pubic hair for the girls according to the
classiﬁcations of Marshall and Tanner
(16,17). Breast stage$B2 or girls at pubic
hair stage $PH2 was considered to be a
marker of pubertal onset. Among the
boys, a testicular volume of$4mL, pu-
bic hair stage $PH2, or boys genital
stage$G2was considered to be amarker
of pubertal onset. A total of 238 offspring
ofmotherswithGDMand256 control off-
spring agreed to have at least one of the
Tanner score examinations performed.
Finally, body composition outcomes were
evaluated in a subset (n = 637) of the off-
spring who underwent DEXA scanning
(Lunar Prodigy Advanced EnCore, includ-
ing pediatric software; GE Healthcare).
Statistical Analyses
Normally distributed, continuous out-
comes were described using the mean
and SD, whereas median and interquartile
range were used for skewed, continuous
outcomes. Differences in anthropometric,
metabolic, and body composition out-
comes between offspring exposed to
GDMandcontrol offspringwereexamined
using linear regression models. For nor-
mally distributed outcome variables, we
calculated b-coefﬁcients and 95% CIs to
estimate mean differences, whereas
skewed variables were log transformed,
and for these we calculated the percent-
age differences and 95% CIs. We used
logistic regression models to analyze pu-
berty status and calculated odds ratios
and 95% CIs.
A priori, we decided to ﬁrst adjust for
offspring age at the clinical examination
and to analyze the age-adjusted estimates
Figure 1—Flowchart of enrollment and examination of women and children in the Diabetes and Women’s Health Study.
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separately for boys and girls to investigate
potential sex-speciﬁc differences. Because
we did not see any marked differences
between male and female offspring in
the effect estimates, we decided to in-
clude offspring sex in our minimally ad-
justed model as a potential confounder
rather than to stratify on sex. To examine
whether observed cardiometabolic differ-
ences were explained by the offspring’s
own degree of adiposity, we included
one model with adjustment for offspring
BMI and one model with additional ad-
justment for offspring WHR. For those
variables that remained statistically sig-
niﬁcantly different between offspring of
mothers with GDM and control offspring
after adjustment for offspring BMI and
WHR, we subsequently conducted anal-
yses in which we adjusted for maternal
prepregnancy BMI (in categories ,18.5,
18.5–24.99, 25–29.99, and $30 kg/m2).
Maternal prepregnancy BMI was ob-
tained from telephone interviews in ges-
tation week 12. We did not adjust for
other potential confounding variables,
since our main aim was to determine
whether any observed differences were
related to maternal obesity or hypergly-
cemia in pregnancy, rather than teasing
out the contribution of a range of other
potential confounding variables.
In addition, we stratiﬁed for maternal
prepregnancy BMI in four groups to ex-
amine whether there were differences
when comparing offspring of mothers
with GDM to control subjects across
groups of maternal prepregnancy BMI.
Additionally, we performed analyses in a
subsampleofwomenwhereGDM(n = 332)
was deﬁned according to best clinical
judgement (14) compared with control
subjects.
RESULTS
Table 1 presents the clinical characteris-
tics of the offspring. There was an even
sex distribution among case patient and
control offspring, but control offspring
were slightly older than offspring of
mothers with GDM at the time of follow-
up, which was due to a time displace-
ment for the examination time for
some of the control offspring. When
we adjusted for this age difference,
the offspring of mothers with GDM
were heavier andhad ahigher BMI, larger
waist and hip circumferences, elevated
WHR, as well as increased systolic blood
pressure and heart rate compared with
control offspring (Table 1). Furthermore,
the offspring of mothers with GDM had
higher fasting whole-blood and fasting
plasma glucose levels, as well as higher
fasting plasma insulin, fasting C-peptide,
and HOMA-IR levels. In addition, the off-
spring of mothers with GDM had an un-
healthier plasma lipid proﬁle with higher
triglyceride and lower HDL levels. Off-
spring of mothers with GDM also had
higher total fat percentages, more ab-
dominal fat, and lower lean body mass
percentages than control offspring.
Among the female offspring of mothers
with GDM, the odds of having reached
puberty based on Tanner stage for breast
development was almost doubled com-
pared with control offspring. No differ-
ences in puberty development were
observed between male offspring of
mothers with GDM and control offspring
(Table 1). After adjustment for puberty
status, we still observed signiﬁcant differ-
ences in the IRmarkers betweenoffspring
of mothers with GDM and control off-
spring (data not shown).
Since adiposity is one of the most im-
portant risk factors for IR, type 2 diabetes
and cardiovascular disease (18),we exam-
ined whether the adverse cardiometa-
bolic proﬁle among offspring of mothers
with GDM was explained by their in-
creased adiposity compared with control
subjects. When adjusted for offspring
BMI, the offspring of mothers with GDM
still had signiﬁcantly higher waist circum-
ference,WHR, fasting plasma glucose lev-
els, fasting insulin levels, and HOMA-IR
levels (Table 2). Blood pressure, fasting
C-peptide levels, lipid proﬁle, and data
on body composition obtained from a
DEXA scanwere not signiﬁcantly different
between the twogroups after adjustment
for offspring BMI (Table 2). In addition,
the association with earlier onset of pu-
berty among female offspring of mothers
with GDM was no longer signiﬁcant after
adjustment for the offspring’s own BMI
(Fig. 2). Adjusting for offspring BMI z score
instead of BMI did not change our results
(data not shown). Additionally, the off-
spring of mothers with GDM displayed
signiﬁcantly higher fasting glucose levels
(OR 1.04 [95% CI 1.02, 1.05]; P, 0.0001)
and HOMA-IR (1.09 [1.02, 1.16]; P =
0.006) after further adjustment for WHR.
As adiposity is highly heritable (19,20),
we subsequently examined whether the
increased BMI, waist circumference, and
WHR together with the adverse metabolic
proﬁle among the offspring of mothers
with GDM could be explained by maternal
obesity before pregnancy. After adjust-
ment for maternal prepregnancy BMI,
the offspring of mothers with GDM still
had higher BMI (Table 2). WHR, waist cir-
cumference, fasting glucose level, and
HOMA-IR were all signiﬁcantly higher in
the offspring of mothers with GDM after
further adjustment for bothoffspring BMI
andmaternal prepregnancy BMI (Table 2).
Interestingly, the difference in the anthro-
pometric, metabolic, and body composi-
tion outcomes between the offspring of
mothers with GDM and control subjects
appeared to be stronger among offspring
whose mothers were of normal weight in
pregnancy (BMI .18.5 and ,25 kg/m2)
compared with overweight (BMI 25–30
kg/m2) or obese (BMI.30 kg/m2) (Table
3). Among obese mothers, no differences
were observed between the offspring of
mothers with GDM and control subjects.
Finally, deﬁning the GDM diagnosis us-
ing best clinical judgement and only in-
cluding offspring with hospital records
indicating aGDMdiagnosis resulted in sim-
ilar or stronger associations, supporting
our ﬁndings in all cases (Supplementary
Table 1).
CONCLUSIONS
We found that 9- to 16-year-old offspring
of GDM mothers had the following char-
acteristics: 1) higher BMI, WHR, and fat
percentages and lower lean mass per-
centages; 2) increased fasting glucose, in-
sulin, C-peptide, HOMA-IR, systolic blood
pressure, and triglyceride levels as well as
reduced HDL cholesterol levels; and 3)
female offspring had an earlier onset of
puberty. Interestingly, after adjustment
for the offspring’s own BMI and maternal
prepregnancy BMI, the offspring ofmoth-
ers with GDM still had signiﬁcantly higher
fasting glucose and HOMA-IR levels and
WHR, but differences in the onset of pu-
berty disappeared.
Previous studies have shown that
exposure to GDM was associated with
higher BMI and waist circumferences, in-
creased subscapula-to-triceps skinfold ra-
tio (21), and increased fat mass and
central adiposity among male offspring
of mothers with GDM (22) and an in-
creased risk of overweight and obesity
among offspring of mothers with GDM
(11). In these studies, the associations
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between maternal hyperglycemia and
offspring adiposity were attenuated but
still signiﬁcant after adjustment for ma-
ternal prepregnancy BMI. In adult off-
spring born to mothers with GDM, BMI
was on average 0.94 kg/m2 greater than
in their brothers born before the mother
received a diagnosis of diabetes, sug-
gesting that it is most likely due to intra-
uterine mechanisms and not to familial
confounding (10). A meta-analysis by
Philipps et al. (6) concluded thatmaternal
diabetes was associated with increased
offspring BMI z score but that this was
no longer signiﬁcant after adjustment
for maternal prepregnancy BMI. How-
ever, only ﬁve studies had data available
on maternal prepregnancy BMI, and four
of these were based on small sample
sizes; the adjusted analyses were made
based on all pregnancies of women with
diabetes and not only on pregnancies af-
fected by GDM. Others studies (23,24)
have found increased total fat percent-
ages and increased lean mass measured
by DEXA scans in prepubertal offspring of
mothers with GDM; however, in these
studies no adjustment for offspring BMI
or maternal prepregnancy BMI was
made. Taken together, our study high-
lights the importance of adjusting for ma-
ternal prepregnancy BMI when analyzing
the impact of maternal hyperglycemia in
pregnancy on an offspring’s degree of
obesity. We a priori chose not to include
birthweight in our analyses, sincewe con-
sidered birth weight to be a mediator of
the association between GDM and later
risk of obesity among the offspring.
Table 1—Anthropometric, metabolic, body composition, and puberty characteristics of offspring of mothers with GDM and
control subjects at ages 9–16 years
Crude measurements
Pa
Age- and sex-adjusted estimates
for mean difference (95% CI) or %
difference (IQR)* Pb
Offspring of mothers
with GDM
Control
offspring
Anthropometric characteristics, N 546–561 590–597
Age (years) 12.1 (1.5) 12.8 (1.5) ,0.001
Sex (boys) 295 (52.6%) 301 (50.4%) 0.68
Weight (kg) 48.5 (12.7) 47.2 (12.1) 0.08 4.66 (3.48, 5.84) ,0.001
Height (cm) 156.8 (11.4) 159.5 (11.4) ,0.001 1.15 (0.27, 2.03) 0.01
BMI (kg/m2)* 18.8 (4.2) 17.9 (3.4) ,0.001 9% (7–11%) ,0.001
Waist (cm) 73.3 (10.6) 69.9 (8.4) ,0.001 4.92 (3.87, 5.98) ,0.001
Hip circumference (cm) 83.8 (9.6) 82.7 (9.3) 0.07 3.47 (2.55, 4.39) ,0.001
WHR 0.87 (0.06) 0.85 (0.05) ,0.001 0.02 (0.01, 0.03) ,0.001
Head circumference (cm) 55.8 (2.1) 55.5 (2.2) 0.18 0.51 (0.28, 0.75) ,0.001
Systolic blood pressure (mmHg) 109.7 (8.6) 109.5 (8.6) 0.75 1.04 (0.06, 2.01) 0.04
Diastolic blood pressure (mmHg) 62.5 (6.0) 62.6 (6.1) 0.84 20.20 (20.92, 0.51) 0.58
Heart rate (bpm) 69.7 (2.1) 68.1 (10.0) 0.001 0.81 (20.34, 1.96) 0.17
Metabolic characteristics, N 468–522 508–559
Whole-blood fasting glucose
(mmol/L)* 4.7 (0.8) 4.5 (0.7) ,0.001 3% (1–5%) 0.001
Fasting plasma glucose (mmol/L)* 5.0 (0.8) 4.8 (0.6) ,0.001 4% (3–6%) ,0.001
Fasting insulin (pmol/L)* 69.4 (47.3) 61.3 (34.7) 0.001 17% (10–24%) ,0.001
Fasting C-peptide (pmol/L) 596 (211) 575 (189) 0.05 51 (28, 74) ,0.001
HOMA-IR* 2.2 (1.6) 1.9 (1.1) ,0.001 21% (14–30%) ,0.001
Triglycerides (mmol/L)* 0.73 (0.4) 0.70 (0.4) 0.58 5% (1–10%) 0.04
HDL cholesterol (mmol/L) 1.5 (0.4) 1.6 (0.4) 0.11 20.07 (20.11, 20.02) 0.004
LDL cholesterol (mmol/L) 2.4 (0.7) 2.3 (0.6) 0.08 0.06 (20.01, 0.14) 0.11
Total cholesterol (mmol/L) 4.3 (0.7) 4.2 (0.7) 0.22 0.03 (20.05, 0.12) 0.47
Body composition measured by
DEXA, N 191 446
Total fat (%) 31.2 (8.1) 27.0 (7.0) ,0.001 3.45 (2.22, 4.69) ,0.001
Total lean mass (%) 66.2 (7.5) 70.1 (6.5) ,0.001 23.21 (24.37, 22.07) ,0.001
Total android tissue (% fat)* 25.6 (20.1) 19.4 (13.8) ,0.001 22% (12–33%) ,0.001
Total gynoid tissue (% fat) 35.3 (8.3) 31.2 (7.8) ,0.001 2.98 (1.71, 4.25) ,0.001
Fat distribution (android/gynoid
ratio) 0.73 (0.2) 0.66 (0.18) ,0.001 0.08 (0.05, 0.12) ,0.001
Total bonemass density (mg/cm2) 0.9 (0.1) 1.0 (0.1) ,0.001 0.02 (0.001, 0.03) 0.04
Puberty status, N 192–238† 176–256†
Girls breast stage, n yes$B2 (%) 141 (59.2%) 169 (66.0%) 0.18 1.99 (1.18, 3.34) 0.01
Girls pubic hair, n yes$PH2 (%) 99 (44.8%) 133 (56.1%) 0.06 1.51 (0.90, 2.55) 0.12
Boys testis size, n yes$4 mL (%) 143 (74.5%) 156 (85.7%) 0.02 0.77 (0.42, 1.41) 0.40
Boys pubic hair, n yes$PH2 (%) 50 (24.3%) 60 (29.6%) 0.02 1.74 (0.92, 3.28) 0.09
Boys genital stage, n yes$G2 (%) 63 (32.6%) 66 (37.5%) 0.07 1.24 (0.72, 2.14) 0.45
For the crude estimate, data are presented as the mean (SD) or *median (interquartile range [IQR]) for normally and non-normally distributed
variables, respectively.When data are adjusted for age and sex, they are presented as eithermean difference when the residuals are normally distributed
or as % difference when data are log transformed. Android tissue % fat, located in the abdominal area; gynoid tissue fat %, located around the hips.
†Values are n (%) and adjusted estimates are OR (95% CI) and are only adjusted for age. aP values calculated using Student t test, Kruskal-Wallis test, or
x2 tests. bP values for age- and sex-adjusted measurements comparing GDM to control offspring.
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However, if we adjusted for birth weight,
there was still a signiﬁcant difference be-
tween offspring of mothers with GDM and
control offspring with regard to adiposity
measurements such as BMI, waist circum-
ference, total fat percentages, and gynoid
and android fat, whereas birth weight per
se independently was associated with off-
springBMIandwaist circumferencebutnot
with DEXA scan results (data not shown).
Our ﬁnding of higher systolic blood
pressure in offspring of mothers with
GDMwas also observed in 3-year-old off-
spring in whom, after adjustment for the
offspring’s skinfold thicknesses, the asso-
ciation between GDM and increased
systolic blood pressure was no longer
signiﬁcant (25). Similar to our ﬁndings, a
meta-analysis showed that offspring of
mothers with GDM had higher systolic
blood pressure but no difference in dia-
stolic blood pressure compared with con-
trol offspring. However, all these studies
had smaller samples of offspring ofmoth-
ers with GDM and no adjustment for off-
spring BMI, and no signiﬁcant association
between offspring systolic blood pressure
and maternal prepregnancy BMI was
found in ﬁve of the studies where data
onmaternal prepregnancy BMI was avail-
able (26). In contrast, in 3- to 17-year-old
offspring of mothers with GDM no
association between GDM and offspring
blood pressure was found (27). However,
the latter study included a smaller sample
size and the GDMdiagnosis was based on
one single question on a questionnaire.
Table 2—Differences in offspring anthropometric and metabolic characteristics comparing offspring of mothers with GDM to
control subjects after adjustment for offspring age, sex, and BMI and maternal prepregnancy BMI
Offspring outcomes
Mean difference or %
difference* (95% CI) Pc
Mean difference or %
difference* (95% CI) Pd
Anthropometric characteristics
BMI (kg/m2)# 4% (2–6%) ,0.0001
Waist circumference (cm) 0.83 (0.30, 1.35) 0.002 0.52 (20.06, 1.08) 0.08
Hip circumference (cm) 0.01 (20.48, 0.49) 0.97
WHR 0.009 (0.003, 0.02) 0.002 0.009 (0.002, 0.02) 0.01
Head circumference (cm) 0.17 (20.05, 0.40) 0.13
Systolic blood pressure (mmHg) 0.30 (20.70, 1.30) 0.55
Diastolic blood pressure (mmHg) 20.63 (21.26, 0.11) 0.09
Heart rate (bpm) 0.82 (20.37, 2.02) 0.17
Metabolic characteristics
Whole-blood fasting glucose (mmol/L)* 2% (1–4%) 0.02 2% (1–4%) 0.02
Fasting plasma glucose (mmol/L)* 4% (1–5%) ,0.0001 4% (2–5%) ,0.0001
Fasting insulin (pmol/L)* 7% (1–13%) 0.04 4% (22 to 11%) 0.18
C-peptide (pmol/L) 8.7 (213, 30) 0.43
HOMA-IR* 11% (4–18%) 0.002 8% (1–16%) 0.02
Triglycerides (mmol/L)* 0% (25 to 5%) 0.92
HDL cholesterol (mmol/L) 20.02 (20.07, 0.02) 0.30
LDL cholesterol (mmol/L) 0.003 (20.07, 0.08) 0.93
Total cholesterol (mmol/L) 20.002 (20.09, 0.09) 0.96
Body composition measured by DEXA
Total fat (%) 0.72 (20.17, 1.61) 0.11
Total lean mass (%) 20.70 (21.54, 0.14) 0.10
Total android tissue (% fat)* 2% (24 to 8%) 0.50
Total gynoid tissue (% fat) 0.56 (20.48, 1.59) 0.29
Fat distribution (android/gynoid ratio) 0.005 (20.02, 0.03) 0.66
Total bone mass density (mg/cm2) 20.007 (20.02, 0.007) 0.30
*Non-normally distributed variables cP adjusted for age, sex, and offspring BMI. dP adjusted for age, sex, offspring BMI, and maternal prepregnancy BMI.
Only variables that were signiﬁcant after adjustment for offspring BMI were further adjusted for maternal prepregnancy BMI. #Adjusted for age, sex,
and maternal prepregnancy BMI.
Figure 2—Differences in offspring puberty status comparing the offspring of mothers with GDM
with control offspring. Odds ratios are adjusted for offspring BMI.
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Our ﬁndings of multiple early distur-
bances in the cardiometabolic system in
offspring of GDM pregnancies are in line
with previous smaller studies. However,
not all previous studies adjusted the dis-
turbances in the cardiometabolic traits
for theoffspring’s owndegree of adiposity
(1,3,28). Similar to our results, other stud-
ies adjusted for offspring BMI and report-
ed an attenuation, but still a signiﬁcant
association, of the impact of GDM on off-
spring insulin insensitivity and risk of fu-
ture type 2 diabetes (29,30). One study
(2) showed that adult offspring born to
women with GDM had reduced insulin
sensitivity compared with offspring from
the background population, also after ad-
justing for sex and overweight. Holder
et al. (31) followed obese adolescents for
an average of 2.8 years and found that
insulin sensitivity at follow-up was signiﬁ-
cantly lower in the group that had been
exposed to GDM (n = 45) in utero after
adjusting for offspring BMI. Additionally,
others have found (32) that greater ma-
ternal glucose concentration in pregnancy
was associated with reduced insulin sen-
sitivity and greater static b-cell response
after ameal tolerance test in 21prepuber-
tal children, independent of the children’s
own fat percentages measured by DEXA
scanning. In the current study, we found
that the C-peptide levels were no longer
signiﬁcantly different between GDM and
control offspring after adjustment for off-
spring BMI, whereas fasting insulin levels
remained signiﬁcant. We speculate that
the difference in levels of statistical signif-
icance represents variations of the assays
used rather than biologically important
differences in insulin and C-peptide kinet-
ics. Indeed, the CI for C-peptide was sub-
stantially larger than the CI for insulin.
Alternatively, the relatively increased
plasma insulin levels compared with plasma
C-peptide levels among offspring of moth-
ers with GDM could reﬂect lower insulin
clearance as a result of IR. C-peptide is
cleared by the kidneys and therefore is
not inﬂuenced by IR (33).
We found that the probability of hav-
ing reached puberty assessed by breast
development, which is considered to be
the gold standard for evaluating puberty
onset and development among girls (34),
was doubled among the offspring of
mothers with GDM. In contrast, others
showed (9) no differences in Tanner
stages among offspring of mothers with
GDM and control offspring in analyses
when boys and girls were analyzed to-
gether. One study (35) showed that
GDMwas associated with a 2-month ear-
lier transition to Tanner stage .2 exam-
ined by pubic hair development among
boys. However, these studies did not ad-
just for offspring BMI. There is a general
agreement that a higher fat mass or
higher BMI among girls is associated
with an earlier onset of puberty (36,37),
which supports our results that the earlier
onset of puberty among female offspring
of mothers with GDM is mainly driven by
the offspring’s BMI and emphasizes the
importance of adjusting for offspring ad-
iposity when addressing the impact of hy-
perglycemia on puberty development.
Our results on stratifyingmaternal pre-
pregnancy BMI suggest that hyperglyce-
mia may be more relevant in the absence
of severe maternal adiposity (i.e., the im-
pact of hyperglycemia on an offspring’s
body composition may be overruled by
severe obesity in the mother). This is in
accordance with the results of a recent
study (38), which was also based on the
DNBC, showing that the effect of ma-
ternal fasting plasma glucose levels in
pregnancy on offspring obesity at 7 years
appeared more pronounced among non-
obese women with GDM compared with
obese womenwith GDM. However, more
studies are needed to understand the
separate role and the combined potential
superimposing effect of maternal hyper-
glycemia and maternal obesity during
pregnancy on offspring metabolic health.
Besidesmaternal obesity andhypergly-
cemia, other factors such as paternal obe-
sity inﬂuence the offspring’s level of
obesity and adiposity. The strengths of
this study included a large sample of preg-
nancies in women with GDM and good
statistical power to examine the long-
term consequences of intrauterine hy-
perglycemia in this longitudinal study
with .10 years of follow-up. Detailed
datawere available on body composition,
cardiometabolic factors, and clinical assess-
ments of puberty onset in the offspring,
allowing for more precise phenotypical
characterization. Since puberty is, among
other factors, characterized by IR (39), it
is an enormous strength in the current
study that we can take the stage of pu-
bertal development into account.
The current study had some limita-
tions. The GDM group contained women
with both conﬁrmed and suspected cases
of GDM andmay therefore have included
women without GDM. Nonetheless, a
sensitivity analysis of groupings based
on the clinician’s best judgement in a sub-
sample of the women did not alter the
results. Another limitation is that a few
smaller departments used the World
Health Organization criteria and not the
commonly used Danish criteria for GDM.
Although detailed clinical datawere avail-
able for the offspring, comparable infor-
mation was not available for mothers or
fathers for the relevant time period. For
example, no detailed measures of mater-
nal body composition were available for
the prepregnancy period, and no data on
paternal health were available to account
for any genetic predisposition. However,
the explained genetic variance for most
complex diseases is #10%, and thus the
impact on our results may not have been
substantial. Misclassiﬁcation of reported
maternal BMI is likely to have been more
prevalent at higher BMI values, and may
have underestimated the frequencies in
the overweight and obese categories.
This would have led to residual confound-
ing in the models adjusting for maternal
BMI. We also lacked data on postnatal
environment and on possible shared so-
cial and familial obesogenic risk factors
such as diet. Dietary information for
both parents and offspring was not avail-
able until the teen years. Although paren-
tal and offspring diets during this time
period were only weakly correlated (A.A.
Bjerregaard, unpublished observations),
we cannot exclude the possibility that
stronger correlations existed earlier in
childhood. Our data on puberty may
also be subjective to selection bias, since
the boys and girls who did not want to
participate in the puberty examination
were often also those that were older
and had attained puberty. Since the
DEXA scanning was only available at the
Copenhagen University Hospital, it was
only offspring examined at this location
who were offered a DEXA scan. This may
have caused some bias, since the mothers
of offspring with a DEXA scan were older,
had higher socioeconomic status, and
lower prepregnancy BMI. However, these
differences were similar for the two expo-
sure groups, which suggests that any pre-
sent bias may be minor. Furthermore, we
cannot exclude that our results to some
extent may be due to other confounding
factors such as socioeconomic status or
breastfeeding duration, rather than hyper-
glycemia and maternal obesity per se.
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In conclusion, we demonstrated that
9- to 16-year-old offspring of mothers
with GDM had higher BMI and WHR,
and higher fat percentages with more ab-
dominal obesity, higher systolic blood
pressure, fasting glucose level, insulin
and C-peptide levels, higher HOMA-IR,
and an earlier onset of puberty among
girls. The association with higher blood
pressure, higher fasting C-peptide levels,
adverse lipid proﬁle, and earlier onset of
puberty seemed driven by offspring BMI,
whereas the offspring of mothers with
GDMstill had higherWHR, fasting glucose
levels, and HOMA-IR even after adjust-
ment for both the offspring’s own BMI
and maternal prepregnancy BMI. This
supports an independent role of hyper-
glycemia in pregnancy programming
body composition as well as IR among
adolescent offspring.
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